Iridian Asset Management LLC CT lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 78,676 shares of the medical research company’s stock after selling 9,288 […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been given a consensus rating of “Moderate Buy” by the fourteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […]
Diametric Capital LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,049 shares of the medical research company’s stock, valued at approximately $1,972,000. Charles River Laboratories International accounts for approximately 0.9% of Diametric Capital LP’s portfolio, making the […]
StockNews.com downgraded shares of Charles River Laboratories International (NYSE:CRL – Get Rating) from a buy rating to a hold rating in a report released on Thursday. Several other research analysts have also weighed in on the company. Guggenheim raised Charles River Laboratories International from a neutral rating to a buy rating and set a $255.00 […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the fourteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average […]